出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2022年6月
骨と関節向け健康補助食品市場 : タイプ（ビタミンD、ビタミンK、カルシウム、コラーゲン、オメガ3脂肪酸、グルコサミン-コンドロイチン）、流通経路、形態（錠剤、カプセル、液体、粉末）、対象消費者、地域別 – 2027年までの世界予測
Bone & Joint Health Supplements Market by Type (Vitamin D, Vitamin K, Calcium, Collagen, Omega 3-Fatty Acid, Glucosamine-Chondroitin), Distribution Channels, Form (Tablets, Capsules, Liquid, Powder), Target Consumers and Region – Global Forecast to 2027
| ページ数 | 256 |
| 図表数 | 222 |
| 種別 | 英文調査報告書 |
| 価格 |
The global bone & joint health supplements market is estimated to be valued at USD 11.7 billion in 2022. It is projected to reach USD 17.6 billion by 2027, recording a CAGR of 8.5% during the forecast period. Rising incomes have prompted households to increase their budgets and spend more on health and nutrition in addition to necessities such as food. Nutrition bars, in addition to protein supplements, are gaining popularity, particularly in urban areas. According to experts, food/sport supplements are becoming more popular, particularly vegetarians, increasingly feel the need to meet their protein requirements in order to stay healthy.
“North America is projected to witness the growth of 7.9% during the forecast period.”
The bone & joint health supplements market in North America is growing at a CAGR of 7.9% due to the rising awareness related to health trends, the popularity of bone & joint health supplements is witnessing a surge in the region. Insufficient exercise, low vitamin D levels, and inadequate calcium are becoming more widely recognized in modern life. Vitamin D deficiency affects around 70% of children in the United States. Adults have been shown to have a similar level of vitamin D deficiency. Vitamin D is found in oily fish such as salmon and swordfish, as well as smaller amounts in tuna and other seafood. Vitamin D is difficult to obtain in sufficient amounts through diet alone. Along with that, insufficient exercise, low vitamin D levels, and inadequate calcium are becoming more widely recognized in modern life. Vitamin D deficiency affects around 70% of children in the United States. Adults have been shown to have a similar level of vitamin D deficiency. More than three-quarters of Americans take nutritional supplements each year, a clear trend that demonstrates the importance of supplementation in their overall health and wellness routines.
“The elderly people segment dominated the bone & joint health supplements market by target consumers. It is estimated at USD 5,410.2 million in 2022.”
It is projected that the elderly people segment by target consumers will witness the highest growth during the forecast period, owing to the increasing aging populations associated with it. Aging gracefully, adopting a healthy lifestyle, staying active are some of the key goals of the majority of the aging population. As one ages, it becomes a challenge to get the right amount of vitamins and minerals for the body. Fortunately, consumption of bone and joint health supplement fills the gap for such deficiencies. Many older adults in the United States take one or more bone and joint supplements either as a pill or drink. Popular supplements include some nutrients that are under consumed among older adults, including calcium and vitamins D and calcium. Among all other vitamins, vitamin D has been consumed at a higher rate. In older adults, vitamin D helps to support skeletal health by building and protecting bones.
“Other distributions channels is fastest growing segment. It is projected to grow at 9.2% during forecast period.”
Others distribution channels includes speciality food stores, convenience stores, direct-to-consumer, fitness institutes, and E-commerce. Many companies and retailers offer online services to facilitate consumers in terms of placing an order as well as delivering the same. Several one-stop shops are present on the web in easing the purchasing process of the consumers. These online retails also offer a variety of options for a particular bone and joint health supplement product at discounted rates than traditional retail prices to attract more customers. Since the last decade, the increased frequency of online shopping had created opportunities to enhance the product sales of leading online players as well as for regional domestic e-retailers, such as Wheafree in India and Healthy Supplies Ltd. in the UK.
Break-up of Primaries:
By Value chain side: Supply side-59%, Demand side-41%
By Designation: CXOs- 31%, Managers- 24%, Executives – 45%
By Region: Europe – 29%, Asia Pacific – 32%, North America – 24%, RoW – 15%
Leading players profiled in this report:
• Bayer AG(Germany)
• Procter & Gamble (US)
• Amway (US)
• Basf SE (Germany)
• Archer Daniels Midland (US)
• Reckitt Benckiser (UK)
• Pfizer (US)
• Vita Life Sciences Ltd (Australia)
• Arazo Nutrition (US)
• Nature’s Sunshine Products, Inc (US)
• (France)
• Glanbia Plc (Ireland)
• Vitawin(India)
• Nutramax Laboratories Consumer Care, Inc(US)
• Simply Supplements(UK)
• Love Life Supplements(UK)
• Now Foods(US)
• Bellavita Healthcare Pvt Ltd(India)
• Vitaco(New Zealand)
• Nutravita(UK)
• Life Extension(US)
• Pure Encapsulations, LLC (US)
• Herbs Nutriproducts Pvt. Ltd. (India)
• Millennium Herbal Care (India)
Research Coverage:
The report segments the bone & joint health supplements market on the basis of type, distribution channel, form, target consumer and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the global starter cultures, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.
Reasons to buy this report:
• To get a comprehensive overview of the bone & joint health supplements market
• To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them
• To gain insights about the major countries/regions in which the bone & joint health supplements market is flourishing
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. – 25)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 INCLUSIONS AND EXCLUSIONS
1.4 REGIONS COVERED
1.5 PERIODIZATION CONSIDERED
1.6 CURRENCY CONSIDERED
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. – 30)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.2 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 ASSUMPTIONS FOR THE STUDY
2.5 RESEARCH LIMITATIONS & ASSOCIATED RISKS
3 EXECUTIVE SUMMARY (Page No. – 41)
4 PREMIUM INSIGHTS (Page No. – 46)
4.1 ATTRACTIVE GROWTH OPPORTUNITIES IN THE BONE & JOINT HEALTH SUPPLEMENTS MARKET
4.2 NORTH AMERICA: BONE & JOINT HEALTH SUPPLEMENT MARKET, BY TYPE & COUNTRY
4.3 BONE & JOINT HEALTH SUPPLEMENT MARKET, BY TARGET CONSUMERS
4.4 BONE & JOINT HEALTH SUPPLEMENT MARKET, BY FORM AND BY REGION
4.5 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY REGION
5 MARKET OVERVIEW (Page No. – 49)
5.1 INTRODUCTION
5.2 MACROECONOMIC INDICATORS
5.2.1 AGING POPULATION
5.2.2 GLOBAL POPULATION IS WITNESSING A HIGH PROPORTION OF OBESITY
5.2.3 KEY FACTS
5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Increase in the prevalence of vitamin D deficiencies across the globe is expected to boost demand
5.3.1.2 Shift in consumer preferences due to the rising health awareness
5.3.1.3 Aging population to drive the market growth
5.3.1.4 Growing retail sale of nutritional & fortified products
5.3.2 RESTRAINTS
5.3.2.1 High R&D investments and high cost of clinical trials
5.3.3 OPPORTUNITIES
5.3.3.1 Rise in the number of osteoporosis patients is anticipated to propel the market demand
5.3.3.2 Food fortification to satisfy consumer awareness about micronutrient deficiencies
5.3.4 CHALLENGES
5.3.4.1 Consumer skepticism associated with nutraceutical products
5.3.4.2 Regulatory influence
6 INDUSTRY TRENDS (Page No. – 58)
6.1 OVERVIEW
6.2 REGULATORY FRAMEWORK
6.2.1 NORTH AMERICA
6.2.1.1 Canada
6.2.1.2 US
6.2.1.3 Mexico
6.2.2 EUROPEAN UNION
6.2.3 ASIA PACIFIC
6.2.3.1 Japan
6.2.3.2 China
6.2.3.3 India
6.2.3.4 Australia & New Zealand
6.2.4 SOUTH AMERICA
6.2.4.1 Brazil
6.2.4.2 Argentina
6.2.5 MIDDLE EAST
6.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.4 TRADE ANALYSIS
6.5 PATENT ANALYSIS
6.6 VALUE CHAIN ANALYSIS
6.6.1 RESEARCH & DEVELOPMENT
6.6.2 MANUFACTURING
6.6.3 PACKAGING AND STORAGE
6.6.4 DISTRIBUTION
6.6.5 END USER
6.7 TRENDS/DISRUPTIONS IMPACTING THE CUSTOMER’S BUSINESS
6.8 ECOSYSTEM/MARKET MAP
6.8.1 MARKET MAP
6.9 TECHNOLOGY ANALYSIS
6.9.1 FOOD MICROENCAPSULATION
6.9.1.1 Encapsulation of Omega-3 to mask the odor
6.9.2 BIOTECHNOLOGY
6.9.3 INNOVATIVE AND DISRUPTIVE TECH
6.9.3.1 Robotics as a key technological trend leading to innovations in the market
6.9.3.2 3D printing to uplift the future of the dietary supplements market with high end products
6.9.3.3 Hologram Sciences: Consumer-facing digital platforms for personalized nutrition and advice
6.10 PORTER’S FIVE FORCES ANALYSIS
6.10.1 DEGREE OF COMPETITION
6.10.2 BARGAINING POWER OF SUPPLIERS
6.10.3 BARGAINING POWER OF BUYERS
6.10.4 THREAT OF SUBSTITUTES
6.10.5 THREAT OF NEW ENTRANTS
6.11 KEY CONFERENCES & EVENTS IN 2022-2023
6.12 KEY STAKEHOLDERS & BUYING CRITERIA
6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
6.12.2 BUYING CRITERIA
6.13 CASE STUDY ANALYSIS
6.13.1 SAFETY ASSESSMENT AND CERTIFICATION DEMAND BY INDUSTRY PLAYERS TO ENSURE TRANSPARENCY
6.13.1.1 Problem statement
6.13.1.2 Solution offered
6.13.1.3 Outcome
6.13.2 FRUNUTTA STARTED OFFERING EASY-TO-USE AND EFFICIENT-TO-TAKE VITAMIN AND MINERAL PILLS THAT DISSOLVE INSTANTLY
6.13.2.1 Problem statement
6.13.2.2 Solution offered
6.13.2.3 Outcome
6.13.3 NOW FOODS AVAILS FLAVOURED DIETARY SUPPLEMENT PRODUCTS
6.13.3.1 Problem statement
6.13.3.2 Solution offered
6.13.3.3 Outcome
6.13.4 BAYER AG: HOW CAN WE MAKE OUR EXTENDED LIFESPAN A HEALTHY ONE?
6.13.4.1 Problem statement
6.13.4.2 Solution offered
6.13.4.3 Outcome
6.14 AVERAGE SELLING PRICES
7 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY TYPE (Page No. – 90)
7.1 INTRODUCTION
7.2 VITAMIN D
7.2.1 DEFICIENCY OF VITAMIN D IS THE KEY FACTOR DRIVING THEIR USAGE
7.3 VITAMIN K
7.3.1 VITAMIN K PLAYS A VITAL ROLE IN BONE HEALTH
7.4 CALCIUM
7.4.1 LACTOSE INTOLERANCE PEOPLE DRIVING THE GROWTH OF CALCIUM SUPPLEMENTS
7.5 COLLAGEN
7.5.1 RISE IN THE AGING POPLUATION IN DEVELOPED COUNTRIES CONTRIBUTES TO HIGHER GROWTH OF THE COLLAGEN MARKET IN FUTURE
7.6 OMEGA 3 FATTY ACID
7.6.1 OMEGA 3 FATTY ACIDS HAVE ANTI-INFLAMMATORY EFFECTS
7.7 GLUCOSAMINE AND CHONDROITIN
7.7.1 HEALTH-CONSCIOUS PEOPLE ARE TAKING GLUCOSAMINE AND CHONDROITIN AS A PREVENTIVE MEASURE AGAINST ARTHRITIS
7.8 OTHER TYPES
7.8.1 VEGAN AND VEGETARIAN PEOPLE ARE DRIVING THE DEMAND FOR PLANT BASED SUPPLEMENTS
8 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY FORM (Page No. – 101)
8.1 INTRODUCTION
8.2 TABLETS
8.2.1 LONG LIFE IS THE KEY TO THE GROWTH OF THE TABLET FORM OF BONE & JOINT HEALTH SUPPLEMENTS
8.3 CAPSULES
8.3.1 FASTER ABSORPTION OF NUTRIENTS THROUGH CAPSULES
8.4 LIQUID
8.4.1 HIGH ABSORPTION OF LIQUIDS UPON CONSUMPTION IS EXPECTED TO PROPEL THE MARKET GROWTH OF LIQUID SUPPLEMENTS
8.5 POWDER
8.5.1 EASY RELEASE OF ACTIVE INGREDIENTS DRIVING THE USAGE OF THE POWDER FORM
8.6 OTHER FORMS
8.6.1 RELATIVELY LOW-COST DRIVING DEMAND OF OTHER SEGMENT
9 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY TARGET CONSUMER (Page No. – 114)
9.1 INTRODUCTION
9.2 INFANTS
9.2.1 ESSENTIAL NUTRIENTS REQUIRED FOR INFANT NUTRITION TRIGGER THE DEMAND FOR BONE & JOINT HEALTH SUPPLEMENTS
9.3 CHILDREN
9.3.1 RISE IN CONSUMPTION OF NUTRIENTS AMONG CHILDREN PROPELLING THE DEMAND FOR BONE & JOINT HEALTH SUPPLEMENTS
9.4 ADULTS
9.4.1 DEFICIENCY OF SEVERAL MINERALS AND VITAMINS IN ADULTS
9.5 PREGNANT WOMEN
9.5.1 REQUIREMENT FOR OPTIMAL NUTRITION DURING PREGNANCY DRIVING THE DEMAND FOR BONE & JOINT HEALTH SUPPLEMENTS
9.6 ELDERLY
9.6.1 NEED FOR CONSUMPTION OF BONE & JOINT HEALTH SUPPLEMENTS BY THE AGING POPULATION
10 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL (Page No. – 123)
10.1 INTRODUCTION
10.2 SUPERMARKETS/HYPERMARKETS
10.2.1 SUPERMARKETS OF DEVELOPED COUNTRIES CONTRIBUTE A MAJOR SHARE OF BONE & JOINT HEALTH SUPPLEMENTS
10.3 PHARMACIES & DRUG STORES
10.3.1 ELDERLY PEOPLE PREFER PHARMACIES OVER CONVENTIONAL STORE
10.4 HEALTH AND BEAUTY STORES
10.4.1 PATIENT-DIRECTED APPROACH DRIVES THE MARKET FOR HEALTH CENTERS, GLOBALLY
10.5 OTHER DISTRIBUTION CHANNELS
10.5.1 EASY ACCESSIBILITY TO A WIDE RANGE OF HEALTH PRODUCTS AIDS SALES OF BONE & JOINT HEALTH SUPPLEMENTS
11 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY REGION (Page No. – 130)
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 Vitamin D deficiency fueling the growth of the market
11.2.2 CANADA
11.2.2.1 Markets for Omega-3 fatty acids, vitamin d, and calcium as bone & joint health supplements gaining an opportunity
11.2.3 MEXICO
11.2.3.1 Malnutrition and obesity triggering the demand for bone & joint health supplements
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 Surge in demand for plant-based food products provides an avenue for herbal supplements
11.3.2 UK
11.3.2.1 Increasing risk of arthritis gaining popularity for bone & joint health supplements
11.3.3 FRANCE
11.3.3.1 Government support for promoting the consumption of nutritional supplements
11.3.4 ITALY
11.3.4.1 Higher prevalence of vitamin d deficiency driving the demand for bone & joint health supplements
11.3.5 SPAIN
11.3.5.1 Consumer preference for clean-label ingredients paving the way for bone & joint health supplement products
11.3.6 REST OF EUROPE
11.3.6.1 Rising aging population and growing awareness about the importance of consuming healthy foods
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.1.1 Elderly and the millennial population are the forefront users of nutritional supplements for bone & joint health
11.4.2 INDIA
11.4.2.1 The millennial population play a key role in driving the demand for bone & joint health supplements
11.4.3 JAPAN
11.4.3.1 Rise in the aging population is driving the growth of the market
11.4.4 REST OF ASIA PACIFIC
11.4.4.1 Surge in the consumption rate of several types of healthy food products helping the growth of nutritional supplements of bone & joint supplements
11.5 SOUTH AMERICA
11.5.1 BRAZIL
11.5.1.1 Increasing obesity is driving the consumers toward bone & joint health supplements
11.5.2 ARGENTINA
11.5.2.1 Increase in the osteoporosis concern influencing the growth of bone & joint health supplements
11.5.3 REST OF SOUTH AMERICA
11.5.3.1 Influence of health and wellness trends contributing to the market growth
11.6 REST OF THE WORLD
11.6.1 AFRICA
11.6.1.1 Prevalence of vitamin deficiency among women and children results in concerning authorities providing food products, including bone & joint health supplements
11.6.2 MIDDLE EAST
11.6.2.1 Use of bone & joint health supplements for the pharmaceuticals and sports nutrition segments
12 COMPETITIVE LANDSCAPE (Page No. – 187)
12.1 OVERVIEW
12.2 HISTORICAL REVENUE ANALYSIS OF KEY PLAYERS
12.3 MARKET SHARE ANALYSIS, 2021
12.4 KEY PLAYER STRATEGIES
12.5 COMPANY EVALUATION QUADRANT (KEY PLAYERS)
12.5.1 STARS
12.5.2 PERVASIVE PLAYERS
12.5.3 EMERGING LEADERS
12.5.4 PARTICIPANTS
12.6 PRODUCT FOOTPRINT
12.7 START-UP/SME EVALUATION QUADRANT (OTHER PLAYERS)
12.7.1 PROGRESSIVE COMPANIES
12.7.2 STARTING BLOCKS
12.7.3 RESPONSIVE COMPANIES
12.7.4 DYNAMIC COMPANIES
12.7.5 NEW PRODUCT LAUNCHES
12.7.6 DEALS
13 COMPANY PROFILES (Page No. – 199)
13.1 KEY PLAYERS
13.1.1 BAYER AG
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.4 MnM view
13.1.1.4.1 Key strengths/Right to win
13.1.1.4.2 Strategic choices made
13.1.1.4.3 Weaknesses and competitive threats
13.1.2 PROCTER & GAMBLE
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 Recent developments
13.1.2.4 MnM view
13.1.2.4.1 Key strengths/Right to win
13.1.2.4.2 Strategic choices made
13.1.2.4.3 Weaknesses and competitive threats
13.1.3 AMWAY
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 Recent developments
13.1.3.4 MnM view
13.1.3.4.1 Key strengths/Right to win
13.1.3.4.2 Strategic choices made
13.1.3.4.3 Weaknesses and competitive threats
13.1.4 BASF SE
13.1.4.1 Business Overview
13.1.4.2 Products offered
13.1.4.3 MnM view
13.1.4.3.1 Key strengths/Right to win
13.1.4.3.2 Strategic choices made
13.1.4.3.3 Weaknesses and competitive threats
13.1.5 ADM
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.5.3 MnM view
13.1.5.3.1 Key strengths/Right to win
13.1.5.3.2 Strategic choices made
13.1.5.3.3 Weaknesses and competitive threats
13.1.6 RECKITT BENCKISER GROUP PLC
13.1.6.1 Business overview
13.1.6.2 MnM view
13.1.6.2.1 Key strengths/Right to win
13.1.6.2.2 Strategic choices made
13.1.6.2.3 Weaknesses and competitive threats
13.1.7 PFIZER
13.1.7.1 Business overview
13.1.7.2 MnM view
13.1.7.2.1 Strengths/Right to win
13.1.7.2.2 Strategic choices made
13.1.7.2.3 Weaknesses and competitive threats
13.1.8 VITA LIFE SCIENCES
13.1.8.1 Business overview
13.1.8.2 MnM view
13.1.8.2.1 Strengths/Right to win
13.1.8.2.2 Strategic choices made
13.1.8.2.3 Weaknesses and competitive threats
13.1.9 NATURE’S SUNSHINE PRODUCTS, INC.
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.9.3 MnM view
13.1.9.3.1 Key strengths/Right to win
13.1.9.3.2 Strategic choices made
13.1.9.3.3 Weaknesses and competitive threats
13.1.10 GLANBIA PLC
13.1.10.1 Business overview
13.1.10.2 Products offered
13.1.10.3 MnM view
13.1.10.3.1 Key strengths/Right to win
13.1.10.3.2 Strategic choices made
13.1.10.3.3 Weaknesses and competitive threats
13.1.11 ARAZO NUTRITION
13.1.11.1 Business overview
13.1.11.2 MnM view
13.1.12 NATURE’S BOUNTY
13.1.12.1 Business overview
13.1.12.2 Products offered
13.1.12.3 Recent developments
13.1.12.4 MNM View
13.1.13 BUTTERFLY AYURVEDA PVT. LTD.
13.1.13.1 Business overview
13.1.13.2 Products offered
13.1.13.3 MnM view
13.1.14 HERBS NUTRIPRODUCTS PVT. LTD.
13.1.14.1 Business overview
13.1.14.2 Products offered
13.1.14.3 Recent developments
13.1.14.4 MnM view
13.1.15 MILLENNIUM HERBAL CARE
13.1.15.1 Business overview
13.1.15.2 Service offered
13.1.15.3 MnM view
13.2 OTHER PLAYERS
13.2.1 VITAWIN
13.2.2 NUTRAMAX LABORATORIES CONSUMER CARE, INC.
13.2.3 SIMPLY SUPPLEMENTS
13.2.4 LOVE LIFE SUPPLEMENTS LTD.,
13.2.5 NOW FOODS
13.2.6 BELLAVITA HEALTHCARE PRIVATE LIMITED
13.2.7 VITACO
13.2.8 NUTRAVITA
13.2.9 LIFE EXTENSION
13.2.10 PURE ENCAPSULATIONS, LLC.
14 ADJACENT AND RELATED MARKETS (Page No. – 244)
14.1 INTRODUCTION
14.2 LIMITATIONS
14.3 DIETARY SUPPLEMENTS MARKET
14.3.1 MARKET DEFINITION
14.3.2 MARKET OVERVIEW
14.4 NUTRACEUTICAL PRODUCTS MARKET
14.4.1 MARKET DEFINITION
14.4.2 MARKET OVERVIEW
14.5 VITAMIN D MARKET
14.5.1 MARKET DEFINITION
14.5.2 MARKET OVERVIEW
14.6 COLLAGEN MARKET
14.6.1 MARKET DEFINITION
14.6.2 MARKET OVERVIEW
15 APPENDIX (Page No. – 249)
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 AVAILABLE CUSTOMIZATIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
LIST OF TABLES (222 Tables)
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2017–2021
TABLE 2 BONE & JOINT HEALTH SUPPLEMENTS MARKET SNAPSHOT, 2022 VS. 2027
TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 ASIA-PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 KEY EXPORTING COUNTRIES WITH EXPORT VALUE OF VITAMINS & VITAMIN SUPPLEMENTS, 2021 (USD MILLION)
TABLE 9 KEY PATENTS PERTAINING TO BONE & JOINT HEALTH SUPPLEMENTS, 2021
TABLE 10 DIETARY SUPPLEMENTRS MARKET: ECOSYSTEM
TABLE 11 BONE & JOINT HEALTH SUPPLEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 12 BONE AND JOINT HEALTH SUPPLEMENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
TABLE 13 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP THREE FORMS (%)
TABLE 14 KEY BUYING CRITERIA FOR TOP THREE FORMS
TABLE 15 BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 16 BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 17 VITAMIN D: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 18 VITAMIN D: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 19 VITAMIN K: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 20 VITAMIN K: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 21 CALCIUM: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY REGION, 2017–2021 (USD MILLION)
TABLE 22 CALCIUM: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 23 COLLAGEN: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY REGION, 2017–2021 (USD MILLION)
TABLE 24 COLLAGEN: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 25 OMEGA 3 FATTY ACID: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 26 OMEGA 3 FATTY ACID: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 27 GLUCOSAMINE AND CHONDROITIN: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 28 GLUCOSAMINE AND CHONDRAITIN: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 29 OTHER TYPES: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 30 OTHER TYPES: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 31 MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY FORM, 2017–2021 (USD MILLION)
TABLE 32 MARKET SIZE, BY FORM, 2022–2027 (USD MILLION)
TABLE 33 MARKET SIZE, BY FORM, 2017–2021 (KILOTONS)
TABLE 34 MARKET SIZE, BY FORM, 2022–2027 (KILOTONS)
TABLE 35 TABLETS: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 36 TABLETS: MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 37 TABLETS: MARKET SIZE, BY REGION, 2017–2021 (KILOTONS)
TABLE 38 TABLETS: MARKET SIZE, BY REGION, 2022–2027 (KILOTONS)
TABLE 39 CAPSULES: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY REGION, 2017–2021 (USD MILLION)
TABLE 40 CAPSULES: MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 41 CAPSULES: MARKET SIZE, BY REGION, 2017–2021 (KILOTONS)
TABLE 42 CAPSULES:MARKET SIZE, BY REGION, 2022–2027 (KILOTONS)
TABLE 43 LIQUID: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 44 LIQUID: MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 45 LIQUID: MARKET SIZE, BY REGION, 2017–2021 (KILOTONS)
TABLE 46 LIQUID: MARKET SIZE, BY REGION, 2022–2027 (KILOTONS)
TABLE 47 POWDER: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY REGION, 2017–2021 (USD MILLION)
TABLE 48 POWDER: MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 49 POWDER: MARKET SIZE, BY REGION, 2017–2021 (KILOTONS)
TABLE 50 POWDER: MARKET SIZE, BY REGION, 2022–2027 (KILOTONS)
TABLE 51 OTHER FORMS: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 52 OTHER FORMS: MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 53 OTHER FORMS: MARKET SIZE, BY REGION, 2017–2021 (KILOTONS)
TABLE 54 OTHER FORMS: MARKET SIZE, BY REGION, 2022–2027 (KILOTONS)
TABLE 55 MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY TARGET CONSUMER, 2017–2021 (USD MILLION)
TABLE 56 BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY TARGET CONSUMER, 2022–2027 (USD MILLION)
TABLE 57 INFANTS: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 58 INFANTS: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 59 CHILDREN: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY REGION, 2017–2021 (USD MILLION)
TABLE 60 CHILDREN: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 61 ADULTS: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY REGION, 2017–2021 (USD MILLION)
TABLE 62 ADULTS: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 63 PREGNANT WOMEN: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 64 PREGNANT WOMEN: MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 65 ELDERLY: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 66 ELDERLY: MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 67 MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY DISTRIBUTION CHANNEL, 2017–2021 (USD MILLION)
TABLE 68 BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022–2027 (USD MILLION)
TABLE 69 SUPERMARKETS/HYPERMARKETS: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 70 SUPERMARKETS/HYPERMARKETS: MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 71 PHARMACIES & DRUG STORES: BONE & JOINT HEALTH MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 72 PHARMACIES & DRUG STORES: MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 73 HEALTH & BEAUTY STORES: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 74 HEALTH & BEAUTY STORES: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 75 OTHER DISTRIBUTION CHANNELS: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY REGION, 2017–2021 (USD MILLION)
TABLE 76 OTHER DISTRIBUTION CHANNELS: BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 77 GLOBAL BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 78 GLOBAL BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 79 GLOBAL BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2017–2021 (KILOTONS)
TABLE 80 GLOBAL BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY REGION, 2022–2027 (KILOTONS)
TABLE 81 NORTH AMERICA: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 82 NORTH AMERICA: MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 83 NORTH AMERICA: MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 84 NORTH AMERICA: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 85 NORTH AMERICA: MARKET SIZE, BY FORM, 2017–2021 (USD MILLION)
TABLE 86 NORTH AMERICA: MARKET SIZE, BY FORM, 2022–2027 (USD MILLION)
TABLE 87 NORTH AMERICA: MARKET SIZE, BY FORM, 2017–2021 (KILOTONS)
TABLE 88 NORTH AMERICA: MARKET SIZE, BY FORM, 2022–2027 (KILOTONS)
TABLE 89 NORTH AMERICA: MARKET SIZE, BY TARGET CONSUMER, 2017–2021 (USD MILLION)
TABLE 90 NORTH AMERICA: MARKET SIZE, BY TARGET CONSUMER, 2022–2027 (USD MILLION)
TABLE 91 NORTH AMERICA: MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017–2021 (USD MILLION)
TABLE 92 NORTH AMERICA: MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022–2027 (USD MILLION)
TABLE 93 US: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 94 US: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 95 CANADA: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY TYPE, 2017–2021 (USD MILLION)
TABLE 96 CANADA: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 97 MEXICO: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 98 MEXICO: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 99 EUROPE: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 100 EUROPE: MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 101 EUROPE: MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 102 EUROPE: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 103 EUROPE: MARKET SIZE, BY FORM, 2017–2021 (USD MILLION)
TABLE 104 EUROPE: MARKET SIZE, BY FORM, 2022–2027 (USD MILLION)
TABLE 105 EUROPE: MARKET SIZE, BY FORM, 2017–2021 (KILOTONS)
TABLE 106 EUROPE: MARKET SIZE, BY FORM, 2022–2027 (KILOTONS)
TABLE 107 EUROPE: MARKET SIZE, BY TARGET CONSUMER, 2017–2021 (USD MILLION)
TABLE 108 EUROPE: MARKET SIZE, BY TARGET CONSUMER, 2022–2027 (USD MILLION)
TABLE 109 EUROPE: MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017–2021 (USD MILLION)
TABLE 110 EUROPE: MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022–2027 (USD MILLION)
TABLE 111 GERMANY: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 112 GERMANY: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 113 UK: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY TYPE, 2017–2021 (USD MILLION)
TABLE 114 UK: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 115 FRANCE: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY TYPE, 2017–2021 (USD MILLION)
TABLE 116 FRANCE: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 117 ITALY: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY TYPE, 2017–2021 (USD MILLION)
TABLE 118 ITALY: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 119 SPAIN: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 120 SPAIN: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 121 REST OF EUROPE: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY TYPE, 2017–2021 (USD MILLION)
TABLE 122 REST OF EUROPE: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 123 ASIA PACIFIC: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 124 ASIA PACIFIC: MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 125 ASIA PACIFIC: MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 126 ASIA PACIFIC: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 127 ASIA PACIFIC: MARKET SIZE, BY FORM, 2017–2021 (USD MILLION)
TABLE 128 ASIA PACIFIC: MARKET SIZE, BY FORM, 2022–2027 (USD MILLION)
TABLE 129 ASIA PACIFIC: MARKET SIZE, BY FORM, 2017–2021 (KILOTONS)
TABLE 130 ASIA PACIFIC: MARKET SIZE, BY FORM, 2022–2027 (KILOTONS)
TABLE 131 ASIA PACIFIC: MARKET SIZE, BY TARGET CONSUMER, 2017–2021 (USD MILLION)
TABLE 132 ASIA PACIFIC: MARKET SIZE, BY TARGET CONSUMER, 2022–2027 (USD MILLION)
TABLE 133 ASIA PACIFIC: MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017–2021 (USD MILLION)
TABLE 134 ASIA PACIFIC: MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022–2027 (USD MILLION)
TABLE 135 CHINA: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 136 CHINA: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 137 INDIA: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY TYPE, 2017–2021 (USD MILLION)
TABLE 138 INDIA: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 139 JAPAN: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 140 JAPAN: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 141 REST OF ASIA PACIFIC: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 142 REST OF ASIA PACIFIC: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 143 SOUTH AMERICA: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 144 SOUTH AMERICA: MARKET SIZE, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 145 SOUTH AMERICA: MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 146 SOUTH AMERICA: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 147 SOUTH AMERICA: MARKET SIZE, BY FORM, 2017–2021 (USD MILLION)
TABLE 148 SOUTH AMERICA: MARKET SIZE, BY FORM, 2022–2027 (USD MILLION)
TABLE 149 SOUTH AMERICA: MARKET SIZE, BY FORM, 2017–2021 (KILOTONS)
TABLE 150 SOUTH AMERICA: MARKET SIZE, BY FORM, 2022–2027 (KILOTONS)
TABLE 151 SOUTH AMERICA: MARKET SIZE, BY TARGET CONSUMER, 2017–2021 (USD MILLION)
TABLE 152 SOUTH AMERICA: MARKET SIZE, BY TARGET CONSUMER, 2022–2027 (USD MILLION)
TABLE 153 SOUTH AMERICA: MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017–2021 (USD MILLION)
TABLE 154 SOUTH AMERICA: MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022–2027 (USD MILLION)
TABLE 155 BRAZIL: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 156 BRAZIL: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 157 ARGENTINA: MARKET SIZE FOR BONE & JOINT HEALTH SUPPLEMENTS, BY TYPE, 2017–2021 (USD MILLION)
TABLE 158 ARGENTINA: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 159 REST OF SOUTH AMERICA: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 160 REST OF SOUTH AMERICA: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 161 REST OF THE WORLD: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY REGION, 2017–2021 (USD MILLION)
TABLE 162 REST OF THE WORLD: MARKET SIZE, BY REGION, 2022–2027 (USD MILLION)
TABLE 163 REST OF THE WORLD: MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 164 REST OF THE WORLD: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 165 REST OF THE WORLD: MARKET SIZE, BY FORM, 2017–2021 (USD MILLION)
TABLE 166 REST OF THE WORLD: MARKET SIZE, BY FORM, 2022–2027 (USD MILLION)
TABLE 167 REST OF THE WORLD: MARKET SIZE, BY FORM, 2017–2021 (KILOTONS)
TABLE 168 REST OF THE WORLD: MARKET SIZE, BY FORM, 2022–2027 (KILOTONS)
TABLE 169 REST OF THE WORLD: MARKET SIZE, BY TARGET CONSUMER, 2017–2021 (USD MILLION)
TABLE 170 REST OF THE WORLD: MARKET SIZE, BY TARGET CONSUMER, 2022–2027 (USD MILLION)
TABLE 171 REST OF THE WORLD: MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017–2021 (USD MILLION)
TABLE 172 REST OF THE WORLD: MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022–2027 (USD MILLION)
TABLE 173 AFRICA: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 174 AFRICA: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 175 MIDDLE EAST: BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 176 MIDDLE EAST: MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 177 BONE & JOINT HEALTH SUPPLEMENT MARKET: DEGREE OF COMPETITION
TABLE 178 COMPANY, BY TYPE FOOTPRINT
TABLE 179 COMPANY, BY APPLICATION FOOTPRINT
TABLE 180 COMPANY, BY REGIONAL FOOTPRINT
TABLE 181 COMPANY, BY OVERALL FOOTPRINT
TABLE 182 DETAILED LIST OF KEY STARTUP/SMES
TABLE 183 BONE & JOINT HEALTH MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES
TABLE 184 BONE & JOINT HEALTH SUPPLEMENTS MARKET: NEW PRODUCT LAUNCHES, 2018–2021
TABLE 185 BONE & JOINT HEALTH SUPPLEMENT MARKET: DEALS, 2018–2021
TABLE 186 BAYER AG: BUSINESS OVERVIEW
TABLE 187 BAYER AG: PRODUCTS OFFERED
TABLE 188 PROCTER & GAMBLE: BUSINESS OVERVIEW
TABLE 189 PROCTER & GAMBLE: PRODUCTS OFFERED
TABLE 190 AMWAY: PRODUCTS OFFERED
TABLE 191 BASF SE: BUSINESS OVERVIEW
TABLE 192 BASF SE: PRODUCTS OFFERED
TABLE 193 ADM: BUSINESS OVERVIEW
TABLE 194 ADM: PRODUCTS OFFERED
TABLE 195 RECKITT BENCKISER GROUP PLC: BUSINESS OVERVIEW
TABLE 196 RECKITT BENCKISER: PRODUCTS OFFERED
TABLE 197 PFIZER: BUSINESS OVERVIEW
TABLE 198 PFIZER: PRODUCTS OFFERED
TABLE 199 VITA LIFE SCIENCES: BUSINESS OVERVIEW
TABLE 200 VITA LIFE SCIENCES: PRODUCTS OFFERED
TABLE 201 NATURE’S SUNSHINE PRODUCTS, INC.: BUSINESS OVERVIEW
TABLE 202 NATURE’S SUNSHINE PRODUCTS, INC.: PRODUCTS OFFERED
TABLE 203 GLANBIA PLC: BUSINESS OVERVIEW
TABLE 204 GLANBIA PLC: PRODUCTS OFFERED
TABLE 205 ARAZO NUTRITION: BUSINESS OVERVIEW
TABLE 206 ARAZO NUTRITION: PRODUCTS OFFERED
TABLE 207 NATURE’S BOUNTY: BUSINESS OVERVIEW
TABLE 208 NATURE’S BOUNTY: PRODUCTS OFFERED
TABLE 209 BUTTERFLY AYURVEDA PVT. LTD.: BUSINESS OVERVIEW
TABLE 210 BUTTERFLY AYURVEDA PVT. LTD.: PRODUCTS OFFERED
TABLE 211 HERBS NUTRIPRODUCTS PVT. LTD.: BUSINESS OVERVIEW
TABLE 212 HERBS NUTRIPRODUCTS PVT. LTD: PRODUCTS OFFERED
TABLE 213 HERBS NUTRIPRODUCTS PVT. LTD.: OTHERS
TABLE 214 MILLENNIUM HERBAL CARE: BUSINESS OVERVIEW
TABLE 215 MILLENNIUM HERBAL CARE: PRODUCTS OFFERED
TABLE 216 ADJACENT MARKETS TO THE FOOD PROCESSING & HANDLING EQUIPMENT MARKET
TABLE 217 DIETARY SUPPLEMENTS MARKET SIZE, BY TYPE, 2017–2021 (USD MILLION)
TABLE 218 DIETARY SUPPLEMENTS MARKET SIZE, BY TYPE, 2022–2027 (USD MILLION)
TABLE 219 NUTRACEUTICAL PRODUCTS MARKET SIZE, BY TYPE, 2017–2025 (USD BILLION)
TABLE 220 VITAMIN D MARKET SIZE, BY ANALOG, 2016–2019 (USD MILLION)
TABLE 221 VITAMIN D MARKET SIZE, BY TYPE, 2020–2025 (USD MILLION)
TABLE 222 COLLAGEN MARKET SIZE, BY SOURCE, 2019–2026 (USD MILLION)
LIST OF FIGURES (61 Figures)
FIGURE 1 MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BONE & JOINT HEALTH SUPPLEMENTS MARKET SIZE ESTIMATION, BY TYPE (SUPPLY-SIDE)
FIGURE 5 MARKET SIZE ESTIMATION (DEMAND-SIDE)
FIGURE 6 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 8 DATA TRIANGULATION
FIGURE 9 MARKET SIZE, BY TYPE, 2022 VS. 2027 (USD BILLION)
FIGURE 10 MARKET SIZE, BY FORM, 2022 VS. 2027 (USD BILLION)
FIGURE 11 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 (USD BILLION)
FIGURE 12 BONE & JOINT HEALTH SUPPLEMENT MARKET SIZE, BY TARGET CONSUMER, 2022 VS. 2027 (USD BILLION)
FIGURE 13 BONE & JOINT HEALTH SUPPLEMENT MARKET SHARE (VALUE), BY REGION, 2021
FIGURE 14 EMERGING ECONOMIES OFFER OPPORTUNITIES FOR MARKET GROWTH
FIGURE 15 VITAMIN D FORMED THE DOMINANT SEGMENT IN TERMS OF TYPE, IN THE NORTH AMERICAN BONE & JOINT HEALTH SUPPLEMENT MARKET
FIGURE 16 ELDERLY SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 17 NORTH AMERICA LED THE BONE & JOINT HEALTH SUPPLEMENTS MARKET IN 2021
FIGURE 18 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE GLOBAL BONE & JOINT HEALTH SUPPLEMENTS MARKET IN 2021
FIGURE 19 POPULATION AGED 65 & ABOVE (% OF TOTAL POPULATION) (2016–2020)
FIGURE 20 DIETARY SUPPLEMENTS MARKET: MARKET DYNAMICS
FIGURE 21 AGING POPULATION IN JAPAN, 2014 – 2021
FIGURE 22 AGING POPULATION IN CHINA, 2014 – 2021
FIGURE 23 AGING POPULATION IN UK, 2014 – 2021
FIGURE 24 AGING POPULATION IN GERMANY, 2014 – 2021
FIGURE 25 PERCENTAGE OF US ADULTS BY AGE TAKING DIETARY SUPPLEMENTS, 2021
FIGURE 26 RETAIL SALE OF NUTRITIONAL AND FORTIFIED PRODUCTS IN AUSTRALIA (USD MILLION), 2018-2022
FIGURE 27 IMPORT TARIFF OF KEY COUNTRIES ON VITAMINS & VITAMIN SUPPLEMENTS, 2020 (%)
FIGURE 28 NO OF PATENTS GRANTED FOR BONE & JOINT HEALTH SUPPLEMENT MARKET, 2011-2021
FIGURE 29 REGIONAL ANALYSIS OF PATENT GRANTED FOR BONE & JOINT HEALTH SUPPLEMENT MARKET, 2011-2021
FIGURE 30 BONE & HEALTH SUPPLEMENTS: VALUE CHAIN ANALYSIS
FIGURE 31 YC-YCC SHIFT FOR THE BONE & JOINT HEALTH SUPPLEMENTS MARKET
FIGURE 32 BONE & JOINT HEALTH SUPPLEMENT MARKET: MARKET MAP
FIGURE 33 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP THREE FORMS
FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE FORMS
FIGURE 35 PRICING ANALYSIS: BONE & JOINT HEALTH SUPPLEMENT MARKET, BY TYPE
FIGURE 36 PRICING ANALYSIS OF KEY PLAYERS: BONE & JOINT HEALTH SUPPLEMENT MARKET, BY REGION
FIGURE 37 PRICING ANALYSIS: BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY FORM (2017–2021), USD/KG
FIGURE 38 PRICING ANALYSIS: BONE & JOINT HEALTH SUPPLEMENT MARKET, BY REGION (2017–2021), USD/KG
FIGURE 39 BONE & JOINT HEALTH SUPPLEMENT MARKET, BY TYPE, 2022 VS 2027 (USD MILLION)
FIGURE 40 BONE & JOINT HEALTH SUPPLEMENT MARKET SHARE, BY FORM, 2022 VS. 2027 (USD MILLION)
FIGURE 41 BONE & JOINT HEALTH SUPPLEMENT MARKET, BY TARGET CONSUMER, 2022 VS. 2027 (USD MILLION)
FIGURE 42 BONE & JOINT HEALTH SUPPLEMENT MARKET, BY DISTRIBUTION CHANNEL, 2022 VS. 2027 (USD MILLION)
FIGURE 43 BONE & JOINT HEALTH SUPPLEMENT MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)
FIGURE 44 INDIA IS EXPECTED TO REGISTER THE HIGHEST CAGR IN THE GLOBAL MARKET FROM 2022 TO 2027
FIGURE 45 NORTH AMERICA: BONE & JOINT HEALTH SUPPLEMENT MARKET SNAPSHOT
FIGURE 46 DEATHS BY DISEASES OF THE MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE IN CANADA
FIGURE 47 ASIA PACIFIC: BONE & JOINT HEALTH SUPPLEMENT MARKET SNAPSHOT
FIGURE 48 JAPAN: COUNTRIES WITH THE LARGEST SHARE OF POPULATION AGED 65 OR OVER, 2019
FIGURE 49 THREE-YEAR TOTAL REVENUE ANALYSIS OF KEY PLAYERS IN THE MARKET, 2019–2021 (USD BILLION)
FIGURE 50 BONE & JOINT HEALTH SUPPLEMENT MARKET: COMPANY EVALUATION QUADRANT, 2021 (KEY PLAYERS)
FIGURE 51 BONE & JOINT HEALTH SUPPLEMENT MARKET: COMPANY EVALUATION QUADRANT, 2021 (OTHER PLAYERS)
FIGURE 52 BAYER: COMPANY SNAPSHOT
FIGURE 53 PROCTER & GAMBLE: COMPANY SNAPSHOT
FIGURE 54 AMWAY: COMPANY SNAPSHOT
FIGURE 55 BASF SE: COMPANY SNAPSHOT
FIGURE 56 ADM: COMPANY SNAPSHOT
FIGURE 57 RECKITT BENCKISER: COMPANY SNAPSHOT
FIGURE 58 PFIZER: COMPANY SNAPSHOT
FIGURE 59 VITA LIFE SCIENCES: COMPANY SNAPSHOT
FIGURE 60 NATURE’S SUNSHINE PRODUCTS, INC.: COMPANY SNAPSHOT
FIGURE 61 GLANBIA PLC: COMPANY SNAPSHOT